Quality of full and final publications reporting acute stroke trials: A systematic review

Stroke

Volumn 29, Issue 10, 1998, Pages 2203-2210

  Bath, Fiona J ^a,b   Owen, Victoria E ^a   Bath, Philip M W ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Quality control; Randomized controlled trials; Stroke management; Stroke, acute

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STROKE; TREATMENT OUTCOME;

EID: 0031667549     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.10.2203     Document Type: Review

References (31)

1. Sandercock PAG, Willems H. Medical treatment of acute ischaemic stroke. Lancet. 1992;339:537-539.
2. Bath PMW. Treating acute ischaemic stroke. BMJ. 1995;311:139-140.
3. International Stroke Trial Collaborative Group . The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997; 349:1569-1581.
4. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 1997;349:1641-1649.
5. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute stroke. N Engl J Med. 1995;333:1581-1587.
6. Wardlaw JM, Yamaguchi T, del Zoppo G. Thrombolytic therapy versus control in acute ischaemic stroke [Cochrane Review]. In: The Cochrane Library, Issue 2. Oxford, UK: Update Software; 1998. Updated quarterly.
7. Mosteller F, Gilbert IP, McPeek B. Reporting standards and research strategies for controlled trials. Control Clin Trials. 1980;1:37-58.
8. Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials: a survey of three medical journals. N Engl J Med. 1987; 317:426-432.
9. Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA. 1994;272:125-128.
10. Bath P, Bath F. Prostacyclin and analogues in acute ischaemic stroke [Cochrane Review]. In: The Cochrane Library, Issue 2. Oxford, UK: Update Software; 1998. Updated quarterly.
11. Bath PMW, Bath FJ, Asplund K. Pentoxifylline, propentofylline and pentifylline in acute ischaemic stroke [Cochrane Review]. In: The Cochrane Library, Issue 2. Oxford, UK: Update Software; 1998. Updated quarterly.
12. Mohiuddin AA, Bath FJ, Bath PMW. Theophylline, aminophylline, caffeine and analogues, in acute ischaemic stroke [Cochrane Review]. In: The Cochrane Library, Issue 2. Oxford, UK: Update Software; 1998. Updated quarterly.
13. The CONSORT Statement. Improving the quality of reporting of randomized controlled trials. JAMA. 1996;276:637-639.
14. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-412.
15. The Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. JAMA. 1994;272:1926-1931.
16. Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Call for comments on a proposal to improve reporting of clinical trials in the biomedical literature. Ann Intern Med. 1994;121:894-895.
17. Siegel S, Castellan NJ. Nonparametric Statistics for the Behavioral Sciences. Singapore: McGraw-Hill Book Co; 1988:1-399.
18. Altman D. Better reporting of randomised controlled trials: the CONSORT statement. BMJ. 1996;313:570-571.
19. Bath FJ, Bath PMW. What is the correct management of blood pressure in acute stroke? The Blood Pressure in Acute Stroke Collaboration. Cerebrovasc Dis. 1997;7:205-213.
20. Chalmers TC, Matta RJ, Smith H Jr, Kunzler AM. Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction. N Engl J Med. 1977;297:1091-1096.
21. Chalmers TC, Celano P, Sacks HS, Smith H. Bias in treatment assignment in controlled clinical trials. N Engl J Med. 1983;309: 1358-1361.
22. Altman D. Randomisation: essential for reducing bias. BMJ. 1991;302: 1481-1482.
23. Olde Rikkert MGM, ten Have HAMJ, Hoefnagels WHL. Informed consent in biomedical studies on aging: survey of four journals. BMJ. 1996;313:1117.
24. Bamford J, Sandercock P, Dennis M, Bum J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
25. Reith J, Jorgensen S, Pedersen P, Nakayama H, Raaschou H, Jeppesen L, Olsen T. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet. 1996;347: 422-425.
26. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997;314:1303-1306.
27. DerSimonian R, Charette LJ, McPeek B, Mosteller F. Reporting on methods in clinical trials. N Engl J Med. 1982;306:1332-1337.
28. Tyson JE, Furzan JA, Reisch JS, Mize SG. An evaluation of the quality of therapeutic studies in perinatal medicine. J Pediatr. 1983;102:10-13.
29. Altman DG, Dore CJ. Randomisation and baseline comparisons in clinical trials. Lancet. 1990;335:149-153.
30. Liberati A, Himel HN, Chalmers TC. A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol. 1986; 4:942-951.
31. Gotzsche PC. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Control Clin Trials. 1989;10:31-56.